These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 15912655

  • 1. [Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation].
    Ramos R, Gómez-Geriqué N, Martínez-Castelao A.
    Nefrologia; 2005; 25(2):178-84. PubMed ID: 15912655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.
    Panzetta O, Cominacini L, Garbin U, Fratta Pasini A, Gammaro L, Bianco F, Davoli A, Campagnola M, De Santis A, Pastorino AM.
    Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710
    [Abstract] [Full Text] [Related]

  • 5. [The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].
    Pirat B, Korkmaz ME, Eroğlu S, Tayfun E, Yildirir A, Uluçam M, Ozin B, Müderrisoğlu H.
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):318-22. PubMed ID: 15590360
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes.
    Farvid MS, Siassi F, Jalali M, Hosseini M, Saadat N.
    Diabetes Res Clin Pract; 2004 Jul; 65(1):21-8. PubMed ID: 15163474
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of vitamin B-6 supplementation on the lipoprotein profile of post-menopausal chronic hemodialysis patients.
    Pike S, Prati RC, Cochran C, Gorman MA, Ashby J, Liepa GU.
    J Am Diet Assoc; 1990 Jul; 90(7):968-72. PubMed ID: 2365939
    [Abstract] [Full Text] [Related]

  • 9. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
    Baldi S, Innocenti M, Frascerra S, Nannipieri M, Lippi A, Rindi P, Ferrannini E.
    J Nephrol; 2013 Jul; 26(3):549-55. PubMed ID: 22941872
    [Abstract] [Full Text] [Related]

  • 10. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women].
    Somogyi A, Herold M, Kocsis I, Nagy G, Somfai G, Studinger P.
    Orv Hetil; 2005 Aug 28; 146(35):1813-8. PubMed ID: 16187540
    [Abstract] [Full Text] [Related]

  • 11. Comparison of antioxidant efficacy of vitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial.
    Singhal S, Gupta R, Goyle A.
    J Assoc Physicians India; 2001 Mar 28; 49():327-31. PubMed ID: 11291971
    [Abstract] [Full Text] [Related]

  • 12. Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc-deficient haemodialysis patients.
    Candan F, Gültekin F, Candan F.
    Cell Biochem Funct; 2002 Jun 28; 20(2):95-8. PubMed ID: 11979503
    [Abstract] [Full Text] [Related]

  • 13. Vitamins and quality of life in hemodialysis patients.
    Mydlik M, Derzsiová K.
    J Nephrol; 2008 Jun 28; 21 Suppl 13():S129-33. PubMed ID: 18446746
    [Abstract] [Full Text] [Related]

  • 14. Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes.
    Tessier DM, Khalil A, Trottier L, Fülöp T.
    Arch Gerontol Geriatr; 2009 Jun 28; 48(1):67-72. PubMed ID: 18077012
    [Abstract] [Full Text] [Related]

  • 15. Effects of vitamin E and vitamin C supplementation on plasma lipid peroxidation and on oxidation of apolipoprotein B-containing lipoproteins in experimental hyperthyroidism.
    Dirican M, Taş S.
    J Med Invest; 1999 Feb 28; 46(1-2):29-33. PubMed ID: 10408154
    [Abstract] [Full Text] [Related]

  • 16. Lipoproteins and lipid peroxidation abnormalities in patients with chronic renal disease.
    Ong-Ajyooth L, Ong-Ajyooth S, Sirisalee K, Nilwarangkur S.
    J Med Assoc Thai; 1996 Aug 28; 79(8):505-12. PubMed ID: 8855633
    [Abstract] [Full Text] [Related]

  • 17. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    Nephrol Dial Transplant; 2008 Sep 28; 23(9):2918-24. PubMed ID: 18436564
    [Abstract] [Full Text] [Related]

  • 18. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L, Shah A, Davies MJ, Rotonda J, Maccubbin D, Tribble D, Veltri E, Mitchel Y.
    Curr Med Res Opin; 2006 May 28; 22(5):823-35. PubMed ID: 16709304
    [Abstract] [Full Text] [Related]

  • 19. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
    Sardo MA, Campo S, Bonaiuto M, Bonaiuto A, Saitta C, Trimarchi G, Castaldo M, Bitto A, Cinquegrani M, Saitta A.
    Curr Med Res Opin; 2005 May 28; 21(5):777-84. PubMed ID: 15969877
    [Abstract] [Full Text] [Related]

  • 20. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 May 28; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.